Studies have found that FERMT2, SLC52A3, TMTC1, GRP, AKAP12, GDF6, SLITRK4, NUDT11, RECK and MAGEH1 genes are associated with tumor progression and prognosis. This evidence concerns the gene TMTC1 and neoplasm.